The starting enamine derivatives 1a,c were allowed to react with different substituted benzylidenemalononitrile derivatives 2a,b to afford the corresponding tetrahydroquinoline-o-aminocarbonitrile derivatives 4a-d. The treatment of 4a-d with conc. H2SO4 at room temperature led to formation of hexahydroquinoline-oaminocarboxamide derivatives 5a-d, while complete hydrolysis had been occurred upon their refluxing with conc. H2SO4 to get the acid analogues 6a-d. Condensation reaction of the derivatives 4a-d with various acid chlorides in pyridine afforded the corresponding hexahydroquinoline-acetamide/benzamide derivatives 7a-d & 8a-d. Furthermore, the compounds 4a-d were fused with urea, thiourea, formamide and acetic anhydride to gain the novel hexa(tetra)hydropyrimido[4,5-b]quinolin derivatives 9a-d, 10a-d, 11a-d and 12a-d, respectively. Some of the newly synthesized analogues were chosen to evaluate their in-vitro cytotoxic activity against human liver carcinoma cell lines (HEPG2). The obtained data revealed that the tested derivatives produced significant activity in comparison with the used reference drug Doxorubicin.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 11575 citations as per Google Scholar report